store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RO5166017 是一种具有口服活性、高效性和选择性的痕量胺相关受体 1(TAAR1)激动剂,可用于研究条件性味觉厌恶额神经障碍。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 1,090 | 现货 | ||
2 mg | ¥ 1,580 | 现货 | ||
5 mg | ¥ 2,480 | 现货 | ||
10 mg | ¥ 3,980 | 现货 | ||
25 mg | ¥ 7,790 | 现货 | ||
50 mg | ¥ 10,700 | 现货 | ||
100 mg | ¥ 14,300 | 现货 |
产品描述 | RO5166017 is an orally active, potent and selective trace amine-associated receptor 1 (TAAR1) agonist for the study of conditioned taste aversion frontal nerve disorders. |
体外活性 | RO5166017 对稳定表达在HEK293细胞中的小鼠/大鼠/食蟹猴/人类TAAR1展现出高亲和力和强大的功能活性,并相对于其他目标展示出高选择性[2]。 |
体内活性 | RO5166017 prevents stress-induced hyperthermia and blocks dopamine-dependent hyperlocomotion in cocaine-treated and dopamine transporter knockout mice, as well as NMDA antagonist-induced hyperactivity[2].Administered orally at doses of 0.01-1 mg/kg, RO5166017 dose-dependently prevents stress-induced hyperthermia in NMRI mice. At doses of 0.1-0.3 mg/kg, RO5166017 exhibits TAAR1-mediated anxiolytic-like properties[2].RO5166017 prevents cocaine-induced hyperlocomotion and inhibits cocaine-induced stereotypies in WT mice, similar to olanzapine, an effect that disappears in Taar1 mice[1].Activation of TAAR1 by RO5166017 increases glucose-dependent insulin secretion in INS1E cells and human islets, and elevates plasma levels of peptide YY (PYY) and glucagon-like peptide 1 (GLP-1) in mice[1]. Chronic treatment of diet-induced obese (DIO) mice with RO5166017 reduces food intake and body weight[1]. |
别名 | RO 5166017, RO-5166017 |
分子量 | 219.28 |
分子式 | C12H17N3O |
CAS No. | 1048346-74-2 |
store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 20 mg/mL (91.21 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 4.5604 mL | 22.8019 mL | 45.6038 mL | 114.0095 mL |
5 mM | 0.9121 mL | 4.5604 mL | 9.1208 mL | 22.8019 mL | |
10 mM | 0.456 mL | 2.2802 mL | 4.5604 mL | 11.4009 mL | |
20 mM | 0.228 mL | 1.1401 mL | 2.2802 mL | 5.7005 mL | |
50 mM | 0.0912 mL | 0.456 mL | 0.9121 mL | 2.2802 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
RO5166017 1048346-74-2 Others RO 5166017 RO5166017 HCl RO-5166017 Inhibitor inhibitor inhibit